Future Diagnostics

Future Diagnostics

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Future Diagnostics is a specialized service provider in the IVD sector, offering comprehensive assay development, optimization, validation, and contract manufacturing services. Its core value proposition is accelerating time-to-market for clients by integrating regulatory compliance (ISO 13485, FDA, IVDR) from the start and utilizing its proprietary micro-SCY™ platform for superior antibody screening. The company serves a global clientele ranging from large multinationals to small biotechs, positioning itself as a technical and regulatory partner rather than just a vendor.

Infectious Disease

Technology Platform

Proprietary micro-SCY™ platform for high-throughput antibody screening and characterization, enabling faster identification of optimal antibody-antigen pairs for robust immunoassay development.

Opportunities

The complex transition to the EU's IVDR creates strong demand for regulatory expertise in assay validation.
The growth of personalized medicine and companion diagnostics (CDx) offers a high-value service expansion area with pharmaceutical companies.

Risk Factors

Revenue is dependent on client R&D budgets, making it susceptible to biotech funding cycles.
Intense competition from larger global CROs/CDMOs and the risk of technological obsolescence of its proprietary platform are key challenges.

Competitive Landscape

Competes with large, full-service CROs (e.g., LabCorp, IQVIA) and specialized IVD CDMOs. Differentiation is achieved through deep, niche expertise in immunoassays, a proprietary screening platform, and integrated regulatory strategy from project inception.